hotspot -WSS

hotspot

author：fashion 2025-09-27 17:50:26 - browse：8

Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourlais, unfortunately, the worst.

My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels. That’s not why Bourla is here. The reason is accountability. Strategic missteps, financial miscalculations, and scientific setbacks have plunged Pfizer into a deep crisis. Bourla is the man at the top, so the responsibility lies with him.

Pfizer shares have fallen 50% this year to their lowest level in more than a decade, erasing nearly $140 billion in market value. In 2022, the company delivered $100 billion in revenue, boosted by a widely used Covid vaccine and Covid treatment. This year, Covid product sales evaporated — and will fall further next year — leaving a vacuum Pfizer is struggling to fill with aging medicines nearing the end of their patent lives, and newer drugs and vaccines that have not performed as expected.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Diagnostic tests are hitting their mathematical limits

focus

Wikipedia

WSS

J&J to emphasize cancer drugs, stop much of its vaccine research

Cigna, Humana reportedly in talks to merge

Crinetics acromegaly drug succeeds in late

30 years of 'Listening to Prozac'

Despite FDA concern, risk that CAR

Despite FDA concern, risk that CAR

leisure time

hotspot

knowledge

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Despite FDA concern, risk that CAR

Moonlake's readout produced a cash windfall. Risks remain

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Continuity nursing helped my family in our darkest PICU moments

CDC director unscathed in first congressional testimony

Moonlake's readout produced a cash windfall. Risks remain

Crinetics acromegaly drug succeeds in late

New air purifier tech could be key to improving indoor air quality

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

explore

AstraZeneca chief proposes a novel edit to the drug pricing bill

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Trump surgeon general acknowledges mistakes during Covid

A rare thyroid diagnosis led to unexpected, all

J&J to emphasize cancer drugs, stop much of its vaccine research

ALS advocates say criticism of new drugs misses bigger picture

focus

focus

Wikipedia

hotspot